Second Merck drug faces inquiry WALL STREET analysts last night said a second experimental pain killer under development by Merck, the American drugs maker, could be delayed until 2007, after regulators asked for more information on the medicines safety. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 